PaxMedica Inc. Gains 47.71%

Fri, Sep 02, 2022 at 07:20 PM
PaxMedica Inc. Gains 47.71%

PaxMedica Inc. (PXMD:NASDAQ) rocketted at $5.17, a gain of 47.7%. On Fri, Sep 02, 2022, PXMD:NASDAQ hit a New 2-Week High of $5.17. The stock appeared on our News Catalysts scanner on Mon, Aug 29, 2022 at 06:04 AM in the 'BIOTECH' category. From Fri, Aug 26, 2022, the stock recorded 60.00% Up Days and 0.00% Green Days

About PaxMedica Inc. (PXMD:NASDAQ)

PaxMedica Inc an early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism...

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.